Sotera Health Company
NASDAQSHC enters the back half of August with a quiet but meaningful shift in tone: a strong earnings reaction last week has pulled short sellers back and prompted a wave of analyst target upgrades, yet the stock still trades well below where most of the Street thinks it belongs. The most notable development this week came from the analyst community. Four firms moved their targets higher…
SHC put-call ratio hits 4.1 standard deviations above mean at 0.0713, signaling extreme call dominance; ratio 21% above 20-day average of 0.0588.
Snapshot as of 20 Sept 2026
SHC enters the back half of August with a quiet but meaningful shift in tone: a strong earnings reaction last week has pulled short sellers back and prompted a wave of analyst target upgrades, yet the stock still…
Sotera Health arrives at mid-week with an unusual combination: short interest up nearly 47% over the past month while Goldman Sachs has just stepped in with a fresh Buy rating and Barclays lifted its target on…
Sotera Health Company posted a Q1 earnings beat this week, reaffirmed its 2026 revenue outlook, and unveiled a CEO transition — yet short interest has climbed more than 50% over the past month, raising an obvious…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SHC — free to start on ORTEX.
Sign up for free →Open SHC on ORTEX